Psychological effect of cervical cancer screening when changing primary screening method from cytology to high‐risk human papilloma virus testing

From 2015, Norway has implemented high‐risk human papilloma virus (hrHPV) testing in primary screening for cervical cancer. Women aged 34–69 years, living in four counties, have been pseudo‐randomly assigned (1:1 randomization) to either hrHPV testing every 5 years (followed by cytology if hrHPV is...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreassen, Trude, Hansen, Bo T., Engesæter, Birgit, Hashim, Dana, Støer, Nathalie C., Tropé, Ameli, Moen, Kåre, Ursin, Giske, Weiderpass, Elisabete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Cancer Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590646/
https://www.ncbi.nlm.nih.gov/pubmed/30549273
http://dx.doi.org/10.1002/ijc.32067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590646/
https://www.ncbi.nlm.nih.gov/pubmed/30549273
http://dx.doi.org/10.1002/ijc.32067

Ejemplares similares